Physician profile
James Tretter
NPI 1629079371
$7,611.51
in general payments reported to CMS, 2019-2025
34 companies · $1,921 in 2025
The $1,921 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $85.67 · 2021: $111 · 2022: $485 · 2023: $1,567 · 2024: $2,615 · 2025: $1,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,487 · Travel and Lodging: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,487.08 |
| Travel and Lodging | $1,615.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,070.82 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Inari Medical, INC. | $1,564.13 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $937.86 | 2019-2024 | Xarelto |
| Stryker Corporation | $505.62 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Medtronic, INC. | $505.02 | 2023-2024 | Endurant Iis, Hawkone, Corevalve Evolut R |
| Silk Road Medical, INC. | $398.42 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Smith+Nephew, INC. | $184.35 | 2019-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Philips North America LLC | $163.44 | 2024 | (P84) Igt Devices Systems, (Br5) Peripheral Ivus, (Az7) Lasers |
| Cook Medical LLC | $141.40 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Abbott Laboratories | $127.89 | 2024-2025 | Jeti All In One Non-Sterile Kit, Esprit |
| Getinge USA Sales, LLC | $108.39 | 2019-2024 | Cardiohelp, Vasoview Hemopro 2 |
| Kerecis Limited | $84.79 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.44 | 2024-2025 | Lifevest |
| Tactile Systems Technology INC | $84.11 | 2024 | Entre Plus, Flexitouch Plus |
| E.R. Squibb & Sons, L.L.C. | $67.97 | 2023 | Eliquis, Camzyos |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $62.70 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Endologix LLC | $57.37 | 2023 | Alto Abdominal Stent Graft System |
| Atricure, INC. | $50.95 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Boston Scientific Corporation | $50.84 | 2025 | Enroute Transcarotid Neuroprotection System |
| Bard Peripheral Vascular, INC. | $43.46 | 2020-2021 | |
| Baxter Healthcare | $39.18 | 2025 | Perclot |
| Acera Surgical, INC. | $33.91 | 2025 | Restrata Wound Matrix |
| Shape Memory Medical INC. | $33.78 | 2025 | Impede Embolization Plug |
| Mid-Atlantic Surgical Systems, LLC | $32.83 | 2025 | |
| Octapharma USA, INC. | $28.80 | 2025 | Fibryga |
| Merck Sharp & Dohme LLC | $22.56 | 2024 | Keytruda |
| Abiomed | $22.04 | 2025 | |
| Ethicon US, LLC | $19.06 | 2023 | Vistaseal, Prolene, Evarrest |
| Integra Lifesciences Corporation | $17.42 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $16.40 | 2022 | |
| Kci USA, INC. | $16.08 | 2019 | |
| Angiodynamics, INC. | $12.06 | 2019 | |
| Terumo Medical Corporation | $11.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tretter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.